Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.57+0.05 (+9.86%)
Close on Nov 13, 2026Market cap $53.35MP/E –Yield –
Citius Oncology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Citius Oncology's pe ratio was 209.0× on Oct 31, 2025, against 141.5× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 209.0× | +71.7 |
| 2024 | Dec 31, 2024 | 137.4× | – |
See a number that looks wrong?